A small-cap waking up fast 📈

*This email contains promotional content

Hey folks, Jeff Bishop here,

Markets closed basically flat yesterday, after both the S&P 500 and Nasdaq hit new intraday records.

We’ve got headlines about tensions in the Strait of Hormuz, uncertainty around negotiations, and yet stocks keep grinding higher anyway.

A big reason why is earnings.

So far this season, companies are beating expectations at a strong clip, and that’s keeping confidence high across the board.

The backdrop of steady macro, strong earnings, and dips getting bought is setting up the perfect environment for the kind of “tactical trade” setups I focus on.

Which brings me to what I’m watching heading into today. Here’s what’s on my radar:

-> A small-cap biotech that just started generating serious revenue from an FDA-approved product

-> Multiple clinical and commercial catalysts that have started stacking up over the past few weeks

-> And a setup that’s steadily gaining momentum

In fact, the stock is already up nearly 15% over the past month.

That’s usually how these moves begin.

They don’t start with a headline. They start with steady accumulation, improving fundamentals, and a chart that begins to turn before the crowd catches on.

Dig a little deeper, this one gets even more interesting.

You’ve got:

-> A late-stage pipeline targeting a massive multi-billion dollar market

-> Strong insider commitment, with leadership putting real money into the business

-> And a valuation gap that doesn’t fully reflect everything the company has going for it

👉 Take a Look Before the Open👈

I broke everything down for you on this page, the full story, the setup, and what could come next.

If this one’s on your radar early, you’ll be in a great position to watch things unfold today.

To Your Success,

P.S. -⚡Daily Action in our Momentum Stock Trading Room from 9am - 4pm ET  

(ALL are welcome)